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Background: Over 50% of patients with chronic heart failure (CHF) have sleep-disordered
breathing (SDB). Any variation in the type of SDB in CHF will have implications for patient
management. Currently there is good evidence for treatment of obstructive sleep apnea
(OSA) in CHF with continuous positive airway pressure; however, for central sleep apnea
(CSA) the treatment is less clear.
Aims: The aim of this study was to investigate the variation in the severity and type of SDB
(OSA vs. CSA) throughout 4 consecutive nights in CHF patients with SDB.
Methods: Nineteen male CHF patients (mean7sd: age 6179 years; left ventricular
ejection fraction: 34710% and percent predicted peak VO2: 67719%) underwent
cardiorespiratory monitoring in their own home throughout 4 consecutive nights.
Results: There was minimal variation in apnea–hypopnea index (AHI) throughout 4 nights
in CHF patients with SDB [intraclass correlation coefﬁcient (95% conﬁdence interval (CI)):
0.97 (95% CI 0.76 and 0.97)]. Eight patients [42% (95% CI 20% and 64%)] demonstrated a
shift in the type of their SDB, from CSA to OSA or vice versa; these patients had
signiﬁcantly smaller neck circumference (group mean7sd) 4272 vs. 4472 cm; p ¼ 0.04),
and had signiﬁcant variation in the central AHI [intraclass correlation coefﬁcient: 0.51 (95%
CI 0.16 and 0.85)].
Conclusions: A single night of cardiorespiratory monitoring is representative of moderate-
to-severe SDB in patients with CHF. However, a high proportion of patients shift their typeElsevier Ltd. All rights reserved.
nd Academic Unit of Sleep & Breathing, National Heart & Lung Institute, Royal Brompton Hospital,
on SW3 6NP, UK. Tel.: +44 7780686629; fax: +44 351 8911.
t.com (A. Vazir).
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A. Vazir et al.832of SDB over 4 nights. These ﬁndings may have implications for the management of SDB
in CHF.
& 2008 Elsevier Ltd. All rights reserved.Introduction
The apnea–hypopnea index (AHI) is the most commonly used
indicator of severity of sleep-disordered breathing (SDB).
There have been a number of studies investigating the
variation in AHI from one night to the next in patients with
obstructive sleep apnea (OSA).1–6 Some of these studies
have assessed variability in AHI throughout 2 nights,4,6 and
others over 3 and 4 nights1,3,5; overall they have revealed
minimal variation in patients with moderate-to-severe OSA.
Whether there is variation in severity of SDB from one night
to the next consecutive night in patients with stable chronic
heart failure (CHF), secondary to left ventricular (LV)
systolic dysfunction, is unknown.
SDB occurs in 50–60% of patients with symptomatic CHF,7,8
with the predominant type of SDB being central sleep apnea
(CSA). However, both central and obstructive respiratory
events may coexist in the same patients.9 Any variation in
the type of SDB from one night to the next is likely to have
important implications for the treatment of SDB in CHF.
There is a growing body of evidence to suggest that it is
beneﬁcial to treat OSA in CHF patients using continuous
positive airway pressure (CPAP) therapy.10,11 However, the
optimal treatment for CSA remains unclear, in light of the
results of the CANPAP study.12,13 Whether there is variation
in the type of SDB from one night to the next consecutive
night in patients with CHF, is unknown.
The aim of this study was to test the hypothesis that there
is minimal variation in the severity and type of SDB
throughout 4 consecutive nights, in male patients with
stable CHF secondary to LV systolic dysfunction and a recent
diagnosis of SDB made by polysomnography.Methods
Patient selection
We prospectively recruited and studied consecutive patients
from cardiology clinics. Eligibility for participation were:
male patients with stable CHF secondary to LV systolic
dysfunction (LV ejection fraction (LVEF) o45%) of at least 6
months duration, due to idiopathic dilated cardiomyopathy
or ischemic cardiomyopathy, in New York Heart Association
(NYHA) Functional classes II–III, and a recent diagnosis of
SDB (AHI 410) made from inpatient nocturnal polysomno-
graphy within a week of recruitment. Stable CHF was
deﬁned as no changes in medication or symptoms for 4
weeks prior to the sleep study and no hospitalisation for48
weeks. All patients were on optimal medical therapy, with
FEV1 and FVC 470% predicted). Exclusion criteria were the
presence of unstable angina, valvular or congenital heart
disease, or chronic respiratory or neurological disease. The
study was approved by the Royal Brompton & Hareﬁeld NHS
Trust ethics committee and all patients gave writteninformed consent. The majority of these patients were also
enrolled in a wider study investigating the prevalence of SDB
in patients with mild symptomatic CHF.8
Study protocol
On entry to the study, patients were evaluated by clinical
examination, and quality of life was assessed using the
Minnesota Living with Heart Failure questionnaire.14 Sub-
jective sleepiness was assessed using the Epworth Sleepiness
Scale.15 This was followed by measurements of spirometry,
2D transthoracic echocardiography, cardiopulmonary exer-
cise test, 12 lead ECG, earlobe arterialised blood gas
sampling, and chemoreﬂex testing. SDB was assessed using
a home cardiorespiratory monitor at the patient’s home. In
addition patients were asked to quantify their consumption
of alcohol and caffeinated drinks on the day and night of
their sleep study.
Measurements
Sleep study
Patients were shown how to use a cardiorespiratory monitor
(Sleepscreen, Jaeger, Germany); they then performed 4
consecutive nights of monitoring. Patients were given
written instructions and a 24 h telephone helpline in case
of any difﬁculties with the monitor. Airﬂow was measured
using nasal pressure cannula. Arterial oxygen saturation was
measured with a ﬁnger pulse-oximeter. Chest and abdominal
excursions were monitored using Piezoelectric voltage effort
bands (Sleepscreen, Jaeger, Germany). Body position was
also recorded. Patients were asked to record the time they
turned off the lights and also the time that they were turned
on in the morning, and requested to note any periods of
overnight wakefulness.
Analysis of overnight cardiopulmonary monitoring
All studies were scored manually by a single scorer blinded
to the results of the cardiac assessments and the order of
the studies. Respiratory events were deﬁned as: obstructive
apnea—complete cessation of airﬂow with continued para-
doxical chest and abdominal movement for 410 s, central
apnea—complete cessation of airﬂow and complete cessa-
tion of chest and abdominal movements for 410 s, mixed
apnea-cessation of airﬂow for 410 s with complete cessa-
tion of both abdominal and chest movement for450% of the
of the apnea (ﬁrst half) followed by paradoxical chest and
abdominal movement in the latter half of the apnea,
hypopnea—a reduction of airﬂow of 450% from baseline
for410 s with or without a oxygen desaturation. They were
further subclassiﬁed into central if chest and abdominal
movement were reduced 450% in amplitude, and obstruc-
tive if abdominal and chest movement was continued and
paradoxical (reduced or zero sum of thoraco-abdominal
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hypopnea is given in Figure 1.
The AHI was calculated for the time the patients
indicated lights out to lights on, which has previously been
shown to be a good assessment of sleep duration.19 If a
patient woke up from sleep to micturate, they would have
to disconnect themselves from the recording monitor; this
would automatically register on the monitor, and taken into
account at the time of the analysis. However, arousals from
sleep lasting seconds or minutes in which the patients woke
up from sleep were not taken into account in the analysis,
unless it was noted by the patient within their question-
naire. Studies were also scored to assess the time spent in
classic Cheyne–Stokes respiration (CSR) during sleep, using
previously deﬁned criteria,20 and expressed as a percen-
tage. The oxygen desaturation index (ODI), the frequency of
X4% oxygen saturation per hour of recording, was also
presented in the study.
The severity of SDB was classiﬁed as mild, moderate and
severe deﬁned by AHI of 5–14.9, 15–29.9 and X30 events/h
of recording, respectively. SDB was further classiﬁed as in
previous studies17,18 as either CSA if more than 50% ofOxygen saturation (%)
Airflow
Chest movement
Abdominal movement
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Oxygen saturation (%)
Airflow
Chest movement
Abdominal movement
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Figure 1 (a) An example of an obstructive hypopnea, with greater
and paradoxical abdominal and chest movement. There are asso
example of a central hypopnea, with more than 50% drop in airﬂo
phase chest and abdominal movements. The central hypopneas areapneas–hypopneas were central (central and mixed apneas)
or OSA if more than 50% of apneas–hypopneas were
obstructive.Cardiac assessment
A complete 2D and Doppler transthoracic echocardiography
study was performed for each patient. LV chamber size was
assessed using M-mode echocardiography, from the left
parasternal long axis view at the level of the tips of the
mitral valve. LVEF was assessed by single plane Simpson’s
method.21 Patients underwent ergometric cardiopulmonary
exercise test (Oxycon, Jaeger Ltd.) from which peak oxygen
uptake (peak VO2) and the slope of ventilation in relation to
carbon dioxide production (VE/VCO2 slope) were calculated.
The percent predicted peak VO2 was also calculated.
22Chemoreﬂex testing
A steady-state constant technique23 was used to assess
chemoreﬂexes to carbon dioxide under normoxia. This
method measures the hypercapnic ventilatory response
(HCVR) close to the physiological range24 as compared to Seconds
0 Seconds
s s s s
sssss
than 50% drop in airﬂow amplitude, with associated continued
ciated oxygen desaturations following the hypopneas. (b) An
w amplitude, with associated continued by lower amplitude in
also followed by oxygen desaturation.
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Table 1 Characteristics of 19 male CHF patients.
Characteristics
Age (years) 6179
Etiology
Ischemic cardiomyopathy, N (%) 9 (47)
Idiopathic cardiomyopathy, N (%) 10 (53)
NYHA, N (%)
II 14 (74%)
III 5 (26%)
Permanent pacemakers, N (%) 3 (16)
ICD, N (%) 1(5)
Atrial ﬁbrillation, N (%) 3 (16)
Diabetes mellitus, N (%) 3 (16)
Renal impairment (creatinine4120 mmol/l),
N (%)
5 (26)
Body mass index (kg/m2) 28.574.2
Spirometry (percent predicted)
FEV1 (%) 79710
FVC (%) 8079
FEV1/FVC ratio 7872.0
Drug therapy, N (%)
ACE inhibitor 15 (79)
Angiotensin II receptor blocker 4 (21)
ACE inhibitor/angiotensin receptor II
blocker
17 (90)
b-Blocker 17 (90)
Diuretic (loop or thiazide diuretic) 17 (90)
Spironolactone 9 (47)
Nitrates 4 (21)
Digoxin 4 (21)
Echocardiography
Left ventricular ejection fraction (%) 33.7710.1
Shortening fraction (%) 21.378.4
Left ventricular end diastolic diameter
(cm)
6.871.0
Left ventricular end systolic diameter
(cm)
5.471.2
Left atrial diameter (cm) 4.670.7
Cardiopulmonary exercise test
Actual peak VO2 (ml/kg/min) 17.374.9
Percent predicted peak VO2 (%) 67719
VE/VCO2 slope 36711.0
Polysomnography, events/hour of sleep
AHI 17 (13–33)
Obstructive AHI 4 (1–14)
Central AHI 12 (3–16)
Obstructive hypopnea index 1 (0.3–3)
Central hypopnea index 3 (1–8)
A. Vazir et al.834the Read rebreath method that assesses HCVR above the
physiological range. The HCVR was calculated from the slope
of the regression line between the mean values for minute
ventilation and end tidal carbon dioxide (PetCO2) for three
increasing loads of carbon dioxide. The HCVR was further
corrected for FEV1 and for age.
25
Statistical analysis
Values are expressed as mean and standard deviation for
data that were normally distributed, or as median and inter-
quartile range for data that was not normally distributed.
For comparison between two groups the unpaired Student’s
t-test and the Mann–Whitney rank sum test were used when
data were normally and non-normally distributed, respec-
tively. Frequency variables between two groups were
assessed by z-test. Pearson’s correlation of coefﬁcient was
used to assess the relationship between two continuous
variables. The intraclass correlation coefﬁcient (ICC) with
95% conﬁdence interval was used to evaluate the consis-
tency in respiratory parameters for each patient throughout
the 4 nights and also between the patients. An ICC value
above 0.75 was taken as indicating excellent reproduci-
bility.26 Results were analysed using Sigmastat version 3.0
and SPSS version 12 (SPSS Inc. Chicago, USA); p values of
o0.05 were considered signiﬁcant.
Results
Patients characteristics
Twenty-three patients agreed to participate, from a total of
38 patients with SDB (AHI410 events/h of sleep from
nocturnal polysomnography) eligible for the study. However,
there were incomplete data sets for four patients, due to
technical failure of the cardiorespiratory monitor to record
on 1 of the 4 nights. The characteristics of the 19 patients
with full data sets are presented in Table 1. All patients had
stable CHF secondary to LV systolic dysfunction and limited
exercise capacity despite being on maximal tolerated
medical therapy. The characteristics of the 19 patients
included within the study were similar to the four excluded
patients (age: 61712 years; LVEF: 30711; percent pre-
dicted peak VO2: 72.6714%; AHI from polysomnography: 26
(11–38) events/h of sleep).
Variation in severity of SDB in CHF patients with SDB
Using the ﬁrst night of the home cardiorespiratory monitor-
ing, two patients had mild SDB, six had moderate SDB and 11
had severe SDB. The AHI and ODI for all 19 patients
throughout 4 consecutive nights is shown in Figure 2a
and b. The mean number of respiratory events throughout
the four nights is presented in Table 2. The highest ICC
values and therefore the least variation were present for
AHI, 0.94 (0.76 and 0.97) and ODI, 0.94 (0.88 and 0.97),
throughout the 4 nights. The obstructive hypopneas index
had the lowest ICC value of 0.42 (0.19 and 0.67). The time in
CSR, central hypopnea, central and obstructive AHI had ICC
values of 0.81 (0.67 and 0.91), 0.73 (0.55 and 0.87), 0.69(0.50 and 0.85) and 0.71 (0.53 and 0.86), respectively,
indicating good reproducibility and therefore consistency.
Thirty-seven percent (7/19 of patients), 95% conﬁdence
interval of 20–64%, showed changes in the severity of SDB
throughout 4 nights of monitoring from moderate-to-severe
SDB or vice versa. These patients did not demonstrate any
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Figure 2 (a) Individual apnea–hypopnea index (AHI) for 19 chronic heart failure (CHF) patients with sleep-disordered breathing
(SDB) throughout 4 consecutive nights. The black circles represent patients who changed their severity of SDB from moderate to
severe or vice versa, from their ﬁrst night of cardiorespiratory monitoring compared to subsequent nights. White circles represent
patients who did not change class of severity of SDB. (b) The variation in individual44% desaturation index in 19 CHF patients with
SDB throughout 4 consecutive nights. Black and white circles as for Figure 1a.
Table 2 Means across 4 nights and intraclass correlation coefﬁcient for respiratory and non-respiratory parameters.
Variables across 4 nights Night 1 Night 2 Night 3 Night 4 Intraclass correlation
coefﬁcient (95%
conﬁdence interval)
Apnea–hypopnea index 32.5713 34.2714 32.1714 32.9712 0.94 (0.76 and 0.97)
Central apnea–hypopnea index 18.779 20710 19.8710 18.779 0.69 (0.50 and 0.85)
Obstructive apnea–hypopnea index 14.9713 13.279 14.8711 15.6717 0.71 (0.53 and 0.86)
Central apnea index 2.972 3.473 3.372 2.372 0.84 (0.67 and 0.93)
Obstructive apnea index 9.377 9.377 9.979 10.7712 0.88 (0.76 and 0.95)
Mixed apnea index 3.174 4.876 3.174 2.473 0.87 (0.74 and 0.94)
Hypopnea index 17.177 16.877 16.779 17.479 0.89 (0.79 and 0.96)
Central hypopnea index 12.577 13.477 13.278 13.977 0.73 (0.55 and 0.87)
Obstructive hypopnea index 5.579 3.473 3.773 3.773 0.42 (0.19 and 0.67)
44% Desaturation index 26.6719 28.6721 23.7718 26.5718 0.94 (0.88 and 0.97)
Cheyne–Stokes respiration time (% of
sleep time)
21723 22723 19718 16718 0.81 (0.67 and 0.91)
% Of time in supine position 39725 43727 39727 35725 0.95 (0.91 and 0.98)
% Of respiratory events in the supine
position
47727 50729 48728 48728 0.94 (0.89 and 0.98)
Recording time (Hours) 7.771 7.172 7.671 7.671 0.88 (0.75 and 0.95)
Intraclass correlation coefﬁcient of 40.75 represents excellent reproducibility. Variables are expressed as mean with standard
deviation. Respiratory events are presented as number of respiratory events per hour of recording.
Sleep-disordered breathing in patients with heart failure 835distinguishing cardiac features when compared to CHF
patients who did not change their class of severity of SDB.
No differences were found between the group of patients
who demonstrated variation in the classiﬁcation of the
severity of SDB compared to those without variation for
percent predicted peak VO2 (76.376.2 vs. 61.8722.2ml/
kg/min; p ¼ 0.11); VE/VCO2 slope [30.2 (26.6–32.1) vs. 36.4
(28.1–47.3); p ¼ 0.18], echo LV EF (35.5710.2 vs. 32.77
10.5%; p ¼ 0.57) or Minnesota scores (26.7713.6 vs.
36722.8; p ¼ 0.35).Shift in type of SDB in CHF from one night to the
next
Three CHF patients who were classiﬁed as CSA on their ﬁrst
nights sleep study shifted to a diagnosis of OSA on nights 2, 3
or 4. Five CHF patients who were classiﬁed as OSA on their
ﬁrst nights sleep study shifted to a diagnosis of CSA on nights
2, 3 or 4. Therefore in total 42% (8/19) of patients shifted
their diagnosis from CSA to OSA or vice versa on nights 2, 3
or 4 (see Figure 3).
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Figure 3 This ﬁgure shows the percentage of total apneas that
were central in origin (central and mixed apneas) for each
individual patient throughout 4 consecutive nights. Patients
were classiﬁed as having central sleep apnea if more than 50%
of apneas and hypopneas were central in origin. Black circles
represent the CHF patients who shifted in their type of sleep-
disordered breathing (SDB) from their ﬁrst night’s sleep study
compared to subsequent nights. White circles represent CHF
patients who did not demonstrate shift in their type of SDB.
A. Vazir et al.836The sleep studies of the nine patients who demonstrated
a shift in the type of SDB from one night to the next were
further analysed by dividing their night’s sleep into a ﬁrst
and second half. Two studies were analysed for each patient
(n ¼ 9 patients) on a night when they were labeled as having
predominately CSA, and on a night when they were labeled
as having predominately OSA. On the night that they had
predominately CSA these patients had a considerable
percentage of respiratory events as obstructive events
(apneas and hypopneas) in the ﬁrst half the night. However,
this was not the case in the second half of the night where
the percentage of obstructive events decreased and the
number of central events increased (1st half, OSA: 43714
vs. CSA: 57714%; p ¼ 0.07: 2nd half, OSA: 35714 vs. CSA:
64714%; p ¼ 0.001). On the night that they had predomi-
nately OSA, these patients demonstrated predominantly
obstructive SDB in both the ﬁrst and second halves of the
night (1st half, OSA 62713 vs. CSA 37713%; p ¼ 0.003: 2nd
half, OSA: 60715 vs. CSA: 40715%; p ¼ 0.017).
There were no differences observed for the severity of
heart failure, chemoreﬂexes or awake PaCO2 between the
eight patients who shifted the type of SDB, compared to the
11 patients who did not: [LVEF (%): 3779 vs. 30710;
p ¼ 0.17, percent predicted peak VO2 (%): 65721 vs.
69718; p ¼ 0.70, Minnesota living with heart failure score
of 29718 vs. 35722; p ¼ 0.53, corrected HCVR (%VE/mmHg
of CO2): 1.970.8 vs. 2.270.9; p ¼ 0.56, PaCO2 (mmHg):
34.473.0 vs. 34.075.0; p ¼ 0.89]. Although patients
demonstrating shift in the type of SDB from the ﬁrst night
compared to consecutive nights had signiﬁcantly smaller
neck circumference, compared to patients not demonstrat-
ing shift (4272 vs. 4472 cm; p ¼ 0.04). Patients who
demonstrated a shift in type of SDB had more variation in
the central AHI [ICC of 0.51 (0.16 and 0.85)] compared to
the obstructive AHI [ICC of 0.64 (0.30 and 0.90)].Relationship between AHI and caffeine, alcohol and
body position
There was minimal variation in the amount of caffeinated
drinks and the amount of alcohol consumed throughout the 4
nights, ICC of 0.98 (0.96 and 0.99) and 0.96 (0.92 and 0.98),
respectively. There was no signiﬁcant relationship between
the amount of caffeine and AHI (r ¼ 0.07, p ¼ 0.54).
A signiﬁcant but weak correlation between alcohol con-
sumption and AHI (r ¼ 0.25, p ¼ 0.03) was observed.
There was no signiﬁcant variation in the percentage of
recording time spent in the supine position across the 4
nights, and no variation in the percentage of respiratory
events occurring in the supine position across the 4 nights,
Table 2. Furthermore, there was no relationship between
the percentage of monitoring time in supine position and AHI
(r ¼ 0.17, p ¼ 0.14).
Discussion
The main ﬁnding of the present study was that the AHI and
ODI showed minimal variation throughout 4 consecutive
nights of monitoring in male CHF patients with moderate-to-
severe SDB. Therefore, a single night of monitoring is
sufﬁcient for the diagnosis of SDB. However, 42% patients
demonstrated a shift in the type of their SDB, changing from
CSA seen on their initial study to OSA, or vice versa, on
subsequent nights. The latter ﬁndings have implications for
the treatment of SDB.
Shift in type of SDB in CHF patients with SDB from
one night to the next
Tkacova and coworkers observed, on a single night, that CHF
patients with predominantly CSA may have relatively more
obstructive events at the beginning of the night, and in the
latter hours develop mainly central events due to worsening
cardiac function.27 In the present study a similar change was
observed in the nine patients who demonstrated shift in the
type of SDB across the 4 nights. In a more recent study,
Tkacova and coworkers28 demonstrated that patients who
shifted from having OSA to CSA over a mean of 7 months,
had a signiﬁcant drop in their end tidal PCO2 (PetCO2) during
the night in which they had CSA. They concluded that the
lowering of the PetCO2 (and therefore PaCO2) during sleep
predisposed patients to CSA, and the former is likely to
occur when OSA worsens cardiac function. Therefore, OSA
may be regarded as primary pathophysiology, whereas the
presence of central events depends on obstructive apneas
leading worsening of cardiac function. We cannot comment
on this mechanism as PetCO2 was not measured overnight
within the present study.
We speculate that obstructive-dependent central events
may hypothetically respond to CPAP treatment, where
alleviation of obstructive events prevents further deteriora-
tion of cardiac function. Currently there is good evidence for
the treatment of OSA in CHF. However, the treatment of CSA
is less clear. The recent CANPAP study revealed that CPAP
therapy improved LVEF and exercise capacity, but did not
improve survival in CHF patients with CSA.12 This may be
related to the fact that not all CHF patients with CSA
ARTICLE IN PRESS
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heart transplant free survival over a 3-month period from
the time of randomization.13
It is unlikely that the variability in body position explained
the shift in type of SDB from OSA to CSA or vice versa within
our study. This is because both central29 and obstructive
respiratory events are likely to occur in the supine position,
and in the present study no signiﬁcant variations were found
in percentage of recording time in the supine position or for
percentage of respiratory events occurring in the supine
position across the 4 nights. Our data are consistent with
previous studies that have failed to demonstrate signiﬁcant
variability in body position from one night to the next.30,31
Although not assessed in this study, other factors that may
inﬂuence the shift from CSA to OSA or vice versa, include
collapsibility of the upper airway during a central apnea and
CSR.32,33 These factors may be important in the present
study, as patients who demonstrated shift in type of SDB had
signiﬁcantly smaller neck circumference, compared to those
who did not. Shifts in ﬂuid retention, or increased central
venous pressure when in the recumbent position may also be
a cause of narrowing of the upper airway.34
Variation in severity of SDB throughout four nights
in CHF with SDB
To date, the majority of studies carried out in patients with
SDB, imply that patients with severe SDB have a poorer
prognosis compared to those with milder disease irrespec-
tive of whether or not they have CHF,36–38 therefore it is
important that the severity of SDB is accurately diagnosed as
these patients are most likely to beneﬁt from treatment.
In the present study there was minimal variation in AHI
throughout the 4 nights. Thus the ﬁrst night of cardior-
espiratory recording is representative of any of the 4 nights.
Seven patients changed their severity of SDB (classiﬁed by
AHI) from moderate to severe or vice versa. Most of the
patients who demonstrated a change in class of severity of
SDB had an AHI within close proximity to the AHI cut-off
level of 30 events/h, such that relatively small changes in
AHI (within 5–10 events/h) were sufﬁcient to change the
classiﬁcation of the severity of SDB from moderate-to-
severe SDB or vice versa.
The present study included mainly CHF patients with
moderate-to-severe SDB. We speculate that there may be a
greater variation of AHI in CHF patients with mild SDB (AHI
5–15 events/h). This idea is supported by studies in mild OSA
patients without CHF.35 In the present study none of the
patients lowered their AHI below the 5 or 10 events/h to be
misclassiﬁed as not having SDB.
Study limitations
Our study may have been strengthened if polysomnography
had been used to determine sleep staging, arousals from
sleep and total sleep time over the 4 nights. Especially as
arousals39 from sleep and change in sleep state40 can
contribute to the pathophysiology and presence of cycles
of central apnea–hypopnea. However, home cardiorespira-
tory monitoring has been shown to be highly speciﬁc and
sensitive for the diagnosis of SDB in the CHF population ascompared to polysomnography.41 Its is a widely available
tool, and use in the diagnosis of SDB has been endorsed by
the Scottish Intercollegiate Guidelines Network/British
Thoracic Society guidelines for the diagnosis and treatment
of OSA.42
The studies were scored by a single-sleep scorer. This may
be a limitation as it could have led to a systematic error in
staging, or random errors. On the other hand, a single scorer
could be considered a strength of the study as it could have
eliminated any potential inter-observer variability across
the 4 nights for each patient and also between the patients.
In addition, our scorer was blinded to the results of the
baseline study and the results of the cardiac assessment.
The criteria used in this study to classify hypopneas and
also apneas into central and obstructive did not have the
accuracy of using a deﬁnitive measure of respiratory drive,
such as intrathoracic negative pressure using an oesophageal
probe. Potentially this could have led to the misclassiﬁca-
tion of some the events, in particular hypopneas. If we had
chosen not to subclassify hypopneas, and based our
classiﬁcation of CSA and OSA by the predominance of
apneas alone (e.g. deﬁning CSA or OSA if more than 50%
of the apneas were central or obstructive, respectively)
then a total of 10/19 (53%) patients would still have shifted
from a diagnosis of OSA to CSA or vice versa across the 4
nights.
The relatively small sample size in our study is in keeping
with initial studies of night-to-night variation in the general
population with OSA.43–45 We acknowledge that the small
sample size can predispose to high variation in severity
and type of SDB from one night to the next. The results
of our study require further validation with a larger
population size, in the order of 460 patients to achieve a
power of 90% to detect shift in type of SDB from one night to
the next.Conclusion
There was minimal variation in AHI from one night to the
next in CHF patients with SDB, thus a single night of home
cardiorespiratory monitoring was representative of the 4
nights in stable CHF patients with moderate-to-severe SDB.
However, 37% of patients demonstrated change in class of
severity of SDB using an AHI cut-off of 30 events/h to
distinguish between moderate and severe SDB. A novel
ﬁnding is that 42 (95% conﬁdence interval; 20–64)% of
patients demonstrated a shift in the type of SDB from one
night to the next. This result may have implications for the
management of SDB in CHF, as the optimal treatment of CSA
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